CERTERRA, INC.

Medtech · Private

Pharmacomap technology: automated high-throughput serial two-photon tomography for whole-brain mapping of drug-evoked neural activation at cellular resolution

Grants
$1.2M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$25K
1 award · Health and Human S
#603 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Improving animal-to-human predictability in clinical trials of mental disorder$600,000
Federal grantDepartment of Health and Human Services · Phase II · Improving animal-to-human predictability in clinical trials of mental disorder$587,276
Federal contractDepartment of Health and Human Services · Ig::ot::ig$25,000
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
600Halo Neuro Inc.$26K$27M
601NANOPROBES INC$26K—
602Simplex Scientific$25K—
603CERTERRA, INC.$25K—
604Alivecor$25K$103M
605SWAN VALLEY MEDICAL, INC$25K$363K
606AVIA BIOSYSTEMS, LLC$25K$1.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.